MPWT
AVDL

MassMutual Private Wealth & Trust’s Avadel Pharmaceuticals AVDL Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-260
Closed -$5.6K – 2398
2025
Q4 		$5.6K Sell
260
-40
-13% -$777 ﹤0.01% 1636
2025
Q3 		$4.58K Buy
+300
New +$3.9K ﹤0.01% 1708

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

MassMutual Private Wealth & Trust's AVDL Position: Q1 2026 in Review

MassMutual Private Wealth & Trust sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 260 shares — an estimated $5.6K sold.

MassMutual Private Wealth & Trust first reported a position in AVDL in Q3 2025 and held it in 2 quarters. The position peaked at $5.6K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • MassMutual Private Wealth & Trust reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 260 Avadel Pharmaceuticals shares in Q1 2026, an estimated $5.6K.
  • MassMutual Private Wealth & Trust first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • MassMutual Private Wealth & Trust's Avadel Pharmaceuticals position peaked at $5.6K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q1 2026, filed 13 Apr 2026.